Treatment Options After Induction Chemotherapy Treatment
Catherine E. Lai, MD, MPH, shares her approach to treatment after a patient with AML completes induction therapy.
Stay updated with breaking news from Optimizing Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Catherine E. Lai, MD, MPH, shares her approach to treatment after a patient with AML completes induction therapy.
A review of recent data regarding maintenance therapy for patients with AML who achieve first remission, including updates from the 2023 ASH Annual meeting.
Insight into monitoring patients who are being treated for AML, what constitutes complete remission, and how and why it’s important to test for minimal residual disease to determine a patient’s risk for relapse.
Expert perspectives on the role of biomarker testing in the diagnosis and management of acute myeloid leukemia.
Catherine E. Lai, MD, MPH, discusses the current standard of care in the first-line treatment of patients with AML and which factors guide therapy selection.